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CytoskeletonAutophagy is a ubiquitous catabolic process involving degradation of damaged organelles and protein
aggregates. It shows cytoprotective effects in many cell types and helps to maintain cell homeostasis.
In many glomerular diseases, podocyte damage leads to the disruption of the renal ﬁltration barrier
and subsequent proteinuria. Puromycin aminonucleoside (PAN) which induces podocyte apoptosis
in vitro and in vivo is widely used for studying the pathophysiology of glomerular diseases. It has been
shown that PAN induces autophagy in podocytes. However, the relationship between autophagy and
apoptosis in PAN treated human podocytes is not known and the role of PAN-induced autophagy in pod-
ocyte survival remains unclear. Here we demonstrate that PAN induced autophagy in human podocytes
prior to apoptosis which was featured with the activation of mTOR complex 1 (mTORC1). When the PAN-
induced autophagy was inhibited by 3-methyladenine (3-MA) or chloroquine (CQ), podocyte apoptosis
increased signiﬁcantly along with the elevation of active caspase-3. Under such circumstance, the podo-
cyte cytoskeleton was also disrupted. Collectively, our results suggested that the induced autophagy may
be an early adaptive cytoprotective mechanism for podocyte survival after PAN treatment.
 2013 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-ND license.1. Introduction
Podocytes are highly differentiated cells which play an extre-
mely important role in guarding the permeability of the tripartite
renal ﬁltration barrier. Many glomerular diseases, such as minimal
change nephropathy and focal segmental glomerulosclerosis
(FSGS), attribute to podocyte damage including apoptosis, cyto-
skeleton rearrangement and detachment [1,2]. Single gene muta-
tions, such as those affecting nephrin and podocin, in podocytes
have also been acknowledged in the pathogenesis of renal diseases
[3,4]. Therefore, podocytes emerge as the therapeutic target of glo-
merular diseases. Since podocytes are terminally differentiated
cells, they are able to cope with various adverse stimuli and repair
themselves efﬁciently. The question of ‘‘How do podocytes survive
longly?’’ initiated our investigation into the cellular protective
mechanisms.Macroautophagy (hereafter referred to as autophagy) is an evo-
lutionary conserved catabolic process [5]. It is involved in process-
ing unwanted cellular materials including misfold proteins,
damaged organelles and invasive microorganisms to the lysosomes
for degradation. The degraded products can be recycled for main-
taining energy homeostasis [6]. Autophagy is being kept at basal
levels in cells for safeguarding and promoting cell survival. This
basal autophagy is one of the major processes that allow cells to re-
spond rapidly to the metabolic stress. Under certain circumstances,
the autophagy can be induced to a higher level to protect cells. For
instance, the induction of autophagy under ischemia in neurons
protects them from apoptosis [7]. Currently, the better known
potential stimuli inducing autophagy include nutrient starvation,
oxidative stress, mitochondrial dysfunction, ischemia–reperfusion
and infection [8,9].
Mammalian target of rapamycin (mTOR) is an evolutionarily
conserved serine/threonine kinase which is the core part of two
complexes: mTOR complex 1 (mTORC1) and mTOR complex 2
(mTORC2). Besides mTOR, mTORC1 also contains mLST8 and Rap-
tor which recruits substrates such as p70 S6 Kinase (p70S6K) for
the phosphorylation by the kinase domain of mTOR. mTORC1 plays
multiple roles in regulating ribosome biogenesis, protein synthesis
and tissue hypertrophy [10]. More importantly, the activation of
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duced when mTORC1 is inhibited by the decreased growth factors
and amino acids during starvation as well as some agents such as
rapamycin [11,12].
Puromycin aminonucleoside (PAN) is widely used for studying
glomerular diseases as it induces podocyte injury in vitro and
in vivo [13,14]. Rats after a single dose of PAN injection will present
with heavy proteinuria, effacement of foot processes and podocyte
loss [15]. Thus, valuable knowledge for understanding the patho-
physiology of renal diseases has been generated based on this
reagent. Recently, it has been reported that PAN can induce
autophagy in podocytes in vitro and in vivo. For instance, Asanuma
et al. found that autophagy was induced in PAN treated condition-
ally immortalized mouse podocytes (MPCs) and in PAN nephrosis
rat model [16]. Another study showed that mTOR-ULK1 pathway
was involved in PAN-induced autophagy in MPCs [17]. In addition,
Hartleben et al. demonstrated that autophagy deﬁcient mice
exhibited more severe albuminuria after PAN treatment than the
wild type [18]. Taken together, these studies demonstrate that
autophagy is essential for podocytes to maintain normal function.
Even though PAN is known to induce podocyte apoptosis, cytoskel-
eton damage and autophagy, the relationship between these
important processes remains unclear. In particular, the role of
PAN-induced autophagy in podocyte survival has not been
elucidated.
In the present study, we found that PAN induced autophagy
prior to apoptosis which was featured with the activation of
mTORC1 in human podocytes. Moreover, when the PAN-induced
autophagy was being blocked by autophagy inhibitors, podocyte
apoptosis increased signiﬁcantly. In addition, we revealed that
the proportion of podocytes with disrupted cytoskeleton dramati-
cally increased after autophagy inhibition. These results suggested
that the induced autophagy may be an early adaptive cytoprotec-
tive mechanism for podocyte survival after PAN treatment.2. Materials and methods
2.1. Cell culture
Conditionally immortalized human podocytes AB8/13 were cul-
tured in RPMI 1640 supplemented with 10% fetal bovine serum
(FBS) (Life Technologies). The human podocytes proliferated at
33 C, with the addition of Insulin–Transferrin–Selenium (Life
Technologies). After growing to 50–60% conﬂuency, cells were
transferred to 37 C for stopping proliferation and achieving full
differentiation in 10–14 days. Fully differentiated human podo-
cytes were treated with different reagents, such as PAN, in RPMI
1640 medium plus 10% FBS at 37 C in a humidiﬁed atmosphere
containing 5% CO2.2.2. Western blotting
Total protein was extracted by RIPA buffer containing a cocktail
of protein inhibitors (Roche Applied Science) and phosphatase
inhibitors (Calbiochem). Protein concentration was determined
by the Bradford assay (Bio-Rad Laboratories). Equal amounts of
denatured proteins were separated by 4–12% SDS–PAGE and trans-
ferred to PVDF membrane (Bio-Rad) which was incubated with pri-
mary antibody and secondary antibody sequentially, visualized
using chemiluminescence substrate (Perkin Elmer). The image
was captured by the ChemiDoc MP system (Bio-Rad) and analyzed
with the Image J software (NIH, USA). LC3, p62, p-mTOR (Ser2448),
T-mTOR, p-p70S6K (Thr389), p70S6K antibodies, anti-rabbit IgG,
HRP linked antibody (Cell Signaling Technology) and b-actin anti-
body (Santa Cruz Biotechnology) have been used.2.3. Immunoﬂuorescence analysis
Podocytes were ﬁxed with 4% paraformaldehyde, blocked with
PBS + 2% BSA and incubated with anti-LC3 antibody (4 C, 12 h).
Then, Alexa Fluor 488 goat anti-rabbit IgG antibody (Life Technol-
ogies) was added (room temperature, 2 h) and washed. After being
mounted with the ProLong Gold Antifade Reagent with DAPI (Life
Technologies), cells were visualised by confocal microscopy (EZ-
C1, Nikon Instrument, Japan). In addition, Alexa Fluor 594 Phalloi-
din (Life Technologies) was used to stain F-actin. The percentage of
podocytes showing accumulation of LC3 puncta (that is with at
least ﬁve puncta per podocyte) and podocyte with disrupted
cytoskeleton was quantiﬁed as the previous study described [19].
At least 100 cells were scored in each of six independent
experiments.
2.4. Flow cytometry
The treated podocytes were harvested and the cell density was
adjusted to 1  106/ml for YO-PRO-1/PI assay (Life Technologies)
and active caspase-3 assay (BD Pharmingen) according to manu-
facturers’ recommendation. Apoptotic cells were measured by
the ﬂow cytometry (FC500, Beckman Coulter) and expressed as a
percentage of total cells. Examples of plots and analysis are in-
cluded in the Supplementary Material.
2.5. Statistical analysis
Data were expressed as mean ± SEM. Multiple groups were
analyzed by Kruskal–Wallis test with post hoc procedures using
the Prism 5.0 Software (GraphPad, San Diego, CA, USA). A p
value < 0.05 was considered to be statistically signiﬁcant.3. Results
3.1. PAN induces autophagy prior to apoptosis in human podocytes
To investigate the relationship between autophagy and apopto-
sis in podocyte, conditionally immortalized human podocytes were
used in the present study. The level of autophagy was evaluated by
the expression of microtubule-associated protein 1A/1B-light
chain 3 (LC3). LC3 is a soluble protein in mammalian cells includ-
ing two forms (LC3-I and LC3-II). The elongation of autophagosome
requires LC3-II which is the conjugated product of LC3-I and phos-
phatidylethanolamine (PE). Thus, the increased LC3-II is regarded
as the standard marker for autophagy activation [20]. As shown
in Fig. 1A, when podocytes were treated with different doses of
PAN for 24 h, the expression of LC3-II increased signiﬁcantly at
the dose of 30 and 50 lg/ml. There was no signiﬁcant difference
between these two doses. Hence, the concentration of 30 lg/ml
was selected for the subsequent experiments.
We found that LC3-II increased after PAN treatment and peaked
at 24 h, but it decreased afterwards and returned nearly to the ba-
sal level at 48 h (Fig. 1B). To conﬁrm the PAN-induced autophagy
detected above, we performed LC3 immunoﬂuorescence staining
in PAN treated podocytes. It is known that LC3-II binds to the auto-
phagosomal membrane and forms puncta in the formation of auto-
phagosome. Therefore, immunoﬂuorescence staining can be used
to analyze LC3 distribution and monitor autophagy in cells. As
shown in Fig. 1C, a large number of bright puncta were visualized
in the cytoplasm of human podocytes at 24 h after PAN treatment.
On the contrary, only very small scattered immunoﬂuorescent dots
were detected in the 0, 12 and 48 h post PAN treatment. The statis-
tical results from LC3 staining are consistent with the data gener-
ated from Western blotting (Fig. 1D).
LC3-I
LC3-II
β-actin
A B
LC3-I
LC3-II
β-actin
C
PAN-0h PAN-12h
PAN-24h PAN-48h
50µm
D E F
Fig. 1. PAN induces autophagy prior to apoptosis in human podocytes. (A) The LC3-II expression increased in a dose-dependent manner after PAN treatment. Conditionally
immortalized human podocytes were treated with 10, 30 and 50 lg/ml of PAN for 24 h. The LC3-II was measured by Western blotting. The data was expressed as the relative
change compared with the control group (CON). A representative immunoblot is shown along with the quantitative data which represents the means ± SEM (n = 5), ⁄⁄p < 0.01
versus CON. (B) The LC3-II expression in podocytes peaked at 24 h after PAN treatment (30 lg/ml). The results represent the means ± SEM (n = 4), ⁄p < 0.05 versus PAN-0 h. (C,
D) Large number of bright LC3 puncta (green) at 24 h after PAN treatment (30 lg/ml) were visualised by confocal microscopy. Representative LC3 immunostaining (green)
and statistical results from 6 independent experiments were shown, ⁄⁄⁄p < 0.001 versus PAN-0 h. The nuclei of the podocytes were stained with DAPI (blue). (E) Acitve
caspase-3 positive podocytes increased at 48 h after PAN treatment, ﬂow cytometry was used for the measurement. n = 4, ⁄p < 0.05 versus PAN-0 h. (F) Podocyte apoptosis
peaked at 48 h after PAN treatment (30 lg/ml). Apoptosis was measured by ﬂow cytometry (YO-PRO-1/PI assay). The representative graphs are shown along with the
statistical results. The results represent the means ± SEM, n = 8, ⁄⁄p < 0.01 versus PAN-0 h. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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permeability as determined by YO-PRO-1/PI assay in this study.
Our data showed that after PAN (30 lg/ml) treatment, the percent-
age of apoptotic podocytes at 24 h was similar to the control
(Fig. 1E), but it increased signiﬁcantly at the 48 h time point. More-
over, active caspase-3 which is the cleaved product of caspase 3
indicates cell undergoing apoptosis. As shown in Fig. 1F, the per-
centage of podocytes with active caspase-3 increased signiﬁcantly
at 48 h after PAN treatment. Taken the data of autophagy and
apoptosis together, it was clearly shown that PAN induced autoph-
agy prior to apoptosis in human podocytes.
3.2. mTORC1 is activated in PAN treated human podocytes
To examine the activity of mTORC1 in PAN treated podocytes,
we measured the levels of phospho-mTOR (p-mTOR) and its down-
stream target marker, phospho-p70S6K (p-p70S6K). It was shown
that the expression of p-mTOR was maintained at the basal level
in the ﬁrst 12 h but increased gradually over time (Fig. 2A). Its
expression was signiﬁcantly higher than the control at 24, 36
and 48 h time points. Similarly, p-p70S6K was induced gradually
over time and reached signiﬁcantly high level after 24 h post
PAN treatment (Fig. 2B).3.3. Inhibition of PAN-induced autophagy increases apoptosis in
human podocytes
Based on our observation of low percentage of apoptotic podo-
cytes but high autophagy at 24 h after PAN treatment, we specu-
lated that autophagy may play a cytoprotective role against
podocyte apoptosis. To verify this hypothesis and investigate the
potential mechanism, two inhibitors were used to suppress
autophagy in PAN treated human podocytes. 3-Methyladenine
(3-MA) blocks autophagy at the initial stage by suppressing class
III Phosphatidylinositol 3-kinases (PI3K), whereas chloroquine
(CQ) increases lysosomal pH, thereby inhibits autolysosomal
degradation, which is featured with accumulation of the two
autophagy substrates LC3-II and p62/SQSTM1 (p62). Additionally,
polyubiquitinated proteins and aggregates can be oligomerized
by p62, and binds to LC3 on the autophagosome membrane, even-
tually damaged organelles or unfolded proteins will be degraded in
the autophagy pathway [21]. Hence, we also measured p62 to con-
ﬁrm the inhibition of autophagy by these inhibitors.
As shown in Fig. 3A, PAN-induced podocyte autophagy was
indicated by the increased LC3-II and decreased p62 levels at
24 h. The addition of 3-MA successfully suppressed the PAN-in-
duced autophagy which was characterized by the low LC3-II and
p-mTOR
T-mTOR
p-p70S6K
p70S6K
A B
Fig. 2. mTORC1 is activated in PAN treated podocytes. (A) The expression level of p-mTOR (Ser2448) in PAN (30 lg/ml) treated podocytes increased signiﬁcantly at 24, 36 and
48 h. The p-mTOR expression level was measured by Western blotting. The data was expressed as the relative change compared with PAN-0 h. A representative immunoblot
is shown along with the quantitative data which represent the means ± SEM (n = 13), ⁄p < 0.05; ⁄⁄p < 0.01 versus PAN-0 h. (B) Similarly, the expression level of p-p70S6K
(Thr389) increased signiﬁcantly at the same time points. A representative immunoblot is shown along with the quantitative data which represent the means ± SEM (n = 9),
⁄⁄p < 0.01; ⁄⁄⁄p < 0.001 versus PAN-0 h.
Fig. 3. The inhibition of PAN-induced autophagy increases podocyte apoptosis. (A) PAN-induced autophagy was inhibited by 3-MA. The expression of LC3-II increased in
podocytes which were treated with PAN (30 lg/ml) for 24 h, it was decreased by 3-MA (5 mM). The expression of p62 decreased in PAN treated podocytes, but it increased
signiﬁcantly after the addition of 3-MA. The representative immunoblot is shown along with the quantitative data which represents the means ± SEM (n = 5), ⁄p < 0.05,
⁄⁄p < 0.01. (B) Podocyte apoptosis increased signiﬁcantly at 24 h after autophagy inhibition. The results represent the means ± SEM (n = 4), ⁄p < 0.05, ⁄⁄p < 0.01 versus CON. (C)
Active caspase-3 positive podocytes increased after autophagy inhibition. Flow cytometry was used for the measurement. The data represent the means ± SEM (n = 4),
⁄p < 0.05, ⁄⁄p < 0.01 versus CON. (D) PAN-induced autophagy was inhibited by CQ. The PAN-induced autophagy was blocked by CQ (25 lM) which resulted in the increased
LC3-II expression. The expression of p62 decreased in PAN treated podocytes, but it increased signiﬁcantly after the addition of CQ. The representative immunoblot is shown
along with the quantitative data which represents the means ± SEM (n = 5), ⁄p < 0.05, ⁄⁄p < 0.01. (E, F) The changes in podocyte apoptosis and the percentage of active caspase-
3 positive podocytes after autophagy inhibition by CQ were similar to 3-MA treatment. n = 5, 4, 4 respectively, ⁄p < 0.05, ⁄⁄⁄p < 0.001 versus CON.
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Fig. 4. The inhibition of PAN-induced autophagy disrupts podocyte cytoskeleton. The podocytes with disrupted F-actin increased when PAN-induced autophagy was
inhibited by 3-MA (5 mM) or CQ (25 lM) for 24 h. Regular bundles of intracellular actin ﬁlaments (red) were observed in untreated cells (CON). The nuclei of the podocytes
were stained with DAPI (blue). PAN, 3-MA and CQ alone slightly disrupted the actin ﬁlaments in podocytes at 24 h. However, cell retraction, the loss of actin-stress ﬁbre
organization and the formation of cortical cytoskeleton were observed in the PAN + 3-MA and PAN + CQ groups. The representative staining pictures are shown along with the
quantitative data which represent means ± SEM from 6 independent experiments, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001 versus CON. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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in podocyte apoptosis (Fig. 3B), along with the percentage of active
caspase-3 positive podocytes (Fig. 3C).
Similarly, CQ arrested autophagy which was presented with
LC3-II and p62 accumulation (Fig. 3D). The blockage of autophagy
by CQ also led to an increase in podocyte apoptosis and the per-
centage of active caspase-3 positive cells (Fig. 3E and F).3.4. Inhibition of PAN-induced autophagy disrupts podocyte
cytoskeleton
Disruption of cytoskeleton is the hallmark of many glomerular
diseases and lead to the podocyte effacement resulting in protein-
uria [22]. To test whether the inhibition of induced autophagy
affects the stability of podocyte cytoskeleton, we checked the sta-
tus of F-actin in human podocytes when the PAN-induced autoph-
agy was inhibited by 3-MA or CQ at 24 h. As shown in Fig. 4,
podocyte cytoskeleton damage was featured with cell retraction,
the loss of actin-stress ﬁbre organization and the formation of cor-
tical cytoskeleton. The percentage of podocytes with disrupted
cytoskeleton increased signiﬁcantly after the inhibition of PAN-in-
duced autophagy.4. Discussion
Autophagy is a conserved catabolic process for keeping cell
homeostasis and serves as the quality control mechanism which is
particularly important for the long lived cells such as neurons. Sim-
ilarly, podocytes are terminally differentiated cells characterized bythe high basal level of autophagy [18], suggesting the signiﬁcance of
autophagy in keeping podocyte homeostasis. Previously PAN has
been shown to induce autophagy inmurine podocytes [16,17]. Here
we reveal the role of the induced autophagy in PAN treated human
podocytes.
In the present study, a relationship between autophagy and
apoptosis was suggested in PAN treated podocytes. We found that
the expression of LC3-II peaked at 24 h, the increased LC3 puncta
were also observed in the cytoplasm at the same time point. Addi-
tionally, our study showed that the induction of autophagy was
transient and the expression of LC3-II nearly dropped to the basal
level at 48 h. Combining with our observation of low percentage of
apoptotic cells at 24 h and peak apoptosis with the increased active
caspase-3 positive podocytes at 48 h, we speculate that PAN in-
duced cell stress in podocytes and triggered both autophagy and
apoptosis. At the early time point, autophagy played a cytoprotec-
tive role to keep apoptosis at the low level. However, as cell stress
persisted over time, autophagy was overridden by apoptosis at
48 h.
The changes of autophagy and apoptosis in PAN treated
podocytes described above may be associated with mTORC1. We
observed a signiﬁcant increase in the level of p-mTOR and
p-p70S6K at 24, 36 and 48 h, suggesting the activation of mTORC1
after PAN treatment. Recently it has been demonstrated that the
mTORC1 activation in diabetic nephropathy leads to the misloca-
tion of slit diaphragm proteins and an epithelial mesenchymal
transition-like phenotypic switch [23]. Thus, we postulate that
the activation of mTORC1 was responsible for the podocyte
apoptosis. In addition, mTORC1 is also known to negatively regu-
late the autophagy. As expected, the increased activity of mTORC1
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time point of 24–48 h). However, it seems to be puzzling at the
time point of 24 h that the peaked autophagy was coupled with
the activated mTORC1. Actually, similar phenomenon has also
been described recently by Huber et al. that high basal autophagy
level was observed in podocytes despite the activation of mTOR
[24]. This interesting ﬁnding could also be explained by the newly
identiﬁed TOR-autophagy spatial coupling compartment (TASCC)
which is located at the site of the Golgi apparatus [25]. TASCC
sequesters cellular mTORC1 with autolysosomes and leads to a
low concentration of mTORC1 in the environment outside the TAS-
CC in favor for autophagy induction. Therefore, TASCC enables the
simultaneous existing of the activation of mTORC1 and autophagy.
In addition, it also can be not excluded that an mTOR-independent
pathway exists in PAN treated podocytes.
Rapamycin, a mTOR inhibitor, has been shown to alleviate pod-
ocyte injury by inducing autophagy [17]. To verify the potential
cytoprotective role of PAN-induced autophagy, we used 3-MA
and CQ to inhibit the autophagy at the early and late stage respec-
tively. Our results showed that 3-MA decreased the expression of
LC3-II, while CQ led to the accumulation of LC3-II, suggesting that
both of them can efﬁciently suppress PAN-induced autophagy.
Consistently, p62 decreased at 24 h after PAN treatment but upreg-
ulated with the addition of 3-MA and CQ, further revealing that
PAN can induce podocyte autophagy and 3-MA or CQ blocked the
PAN-induced autophagy ﬂux. Thus, it suggested that the damaged
cellular components caused by PAN treatment accumulated in
podocytes and could not proceed for degradation. Furthermore, it
has been reported that the accumulation of p62 promotes cellular
stress that leads to diseases [26]. As a consequence, podocyte
apoptosis increased after 24 h, along with the upregulation of ac-
tive caspase-3 positive podocytes, further showing the death path-
way was activated. Therefore, the PAN-induced autophagy was
essential for protecting podocyte against apoptosis in the ﬁrst
24 h after treatment.
The disruption of podocyte cytoskeleton is commonly recog-
nized as the key pathological changes in glomerular diseases
[27]. It is also known that F-actin depolymerization occurs before
the formation of apoptotic bodies and is an early step of apoptosis.
In the present study, we showed that the percentage of podocytes
with disrupted F-actin increased signiﬁcantly when the PAN-in-
duced autophagy was being inhibited. Therefore, it suggested that
PAN-induced autophagy may play a critical role in maintaining the
stability of podocyte cytoskeleton and prevented podocytes from
undergoing apoptosis.
In this study, we have provided direct evidence that inhibition
of PAN-induced autophagy increases podocyte apoptosis. The in-
duced autophagy may be an early adaptive protective mechanism
for PAN-treated podocytes. Since both apoptosis and autophagy
were triggered by PAN, there may be common signals that involve
similar downstream signaling molecules. The crosstalk between
the cell death pathways may contribute to the functional link be-
tween autophagy and apoptosis. We reason that by modulating
the molecules involved in podocyte autophagy, the effect of apop-
tosis will be ameliorated and this cytoprotective role of autophagy
may be harnessed for the treatment of glomerular diseases in the
future.
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